These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8437282)

  • 1. The effects of focused extracorporeal pyrotherapy on a human bladder tumor cell line (647 V).
    Chartier-Kastler E; Chopin D; Vallancien G
    J Urol; 1993 Mar; 149(3):643-7. PubMed ID: 8437282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Focused extracorporeal pyrotherapy. Initial experimental results].
    Vallancien G; Chopin D; Davila C; Guiillonneau B; Perreira E; Veillon B; Brisset JM; Andre-Bougaran J
    Prog Urol; 1991 Feb; 1(1):149-53. PubMed ID: 1285392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy.
    Vallancien G; Harouni M; Guillonneau B; Veillon B; Bougaran J
    Urology; 1996 Feb; 47(2):204-7. PubMed ID: 8607235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focused extracorporeal pyrotherapy.
    Vallancien G; Chartier-Kastler E; Bataille N; Chopin D; Harouni M; Bougaran J
    Eur Urol; 1993; 23 Suppl 1():48-52. PubMed ID: 7685697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focussed extracorporeal pyrotherapy: experimental results.
    Vallancien G; Chartier-Kastler E; Chopin D; Veillon B; Brisset JM; André-Bougaran J
    Eur Urol; 1991; 20(3):211-9. PubMed ID: 1726638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused extracorporeal pyrotherapy: experimental study and feasibility in man.
    Vallancien G; Chartier-Kastler E; Harouni M; Chopin D; Bougaran J
    Semin Urol; 1993 Feb; 11(1):7-9. PubMed ID: 7682004
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppressive effect of high energy shock waves on tumor cells.
    Chen CL; Guo ZH; Zhao Y; Yan CY; Pu JX; Chen ZX; Zhang R
    Chin Med J (Engl); 1991 Jul; 104(7):548-51. PubMed ID: 1879217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines.
    Matzkin H; Rangel MC; Soloway MS
    J Urol; 1992 Jun; 147(6):1671-4. PubMed ID: 1593718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ preservation in superficial bladder cancer.
    Oosterhof GO; Witjes JA; Debruyne FM
    Prog Clin Biol Res; 1991; 370():195-202. PubMed ID: 1924451
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Assessment of conservative management for stage T10N0M0 transitional cell carcinoma of the bladder.
    Lamm DL
    J Urol; 1997 Mar; 157(3):963-4. PubMed ID: 9072621
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of leiomyoma of the urinary bladder associated with transitional cell carcinoma].
    Soga N; Komeda Y; Kawamura J
    Hinyokika Kiyo; 1996 Jun; 42(6):457-9. PubMed ID: 8741303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of transitional cell carcinoma of the bladder.
    Murshidi MS
    Arch Esp Urol; 1989 Mar; 42(2):172-5. PubMed ID: 2735783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-invasive bladder tumour: can the bladder be preserved?
    Sella A
    BJU Int; 2008 Nov; 102(9):1053-4. PubMed ID: 18715247
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of cancer of the bladder].
    Escudero Barrilero A
    Arch Esp Urol; 1989; 42(1):1-7. PubMed ID: 2653234
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of therapy on carcinoembryonic antigen activity in the urines of patients with cancer of the bladder.
    James K; Alroy J; Miller AW; Flanagan M
    Am J Clin Pathol; 1980 Feb; 73(2):250-3. PubMed ID: 6766663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.
    Vögeli TA
    BJU Int; 2005 Dec; 96(8):1171-6. PubMed ID: 16285875
    [No Abstract]   [Full Text] [Related]  

  • 18. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H
    Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077
    [No Abstract]   [Full Text] [Related]  

  • 19. New generation of prognostic factors in muscle invasive bladder cancer.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):47-9. PubMed ID: 8701811
    [No Abstract]   [Full Text] [Related]  

  • 20. A new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer.
    Hudson MR
    J Urol; 1996 Sep; 156(3):972-4. PubMed ID: 8709376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.